Form 4: Pfizer Director Echevarria Reports Acquisition of Phantom Stock Units

Director Joseph Echevarria reports acquisition of phantom stock units in Pfizer Inc. through a non-funded deferred compensation plan.

Summary

• On April 25, 2024, Joseph Echevarria, a director of Pfizer Inc., acquired 8,115.598 phantom stock units.
• The acquisition was made pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.
• The price of the phantom stock units was $25.26.
• Following the transaction, Echevarria directly owns 113,235.566 phantom stock units.
• These units represent deferred director's compensation that are settled in cash or common stock at the director's election following retirement from the Board of Directors.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard compensation practices and aligns director interests with the company's performance.

Positives

• The acquisition of phantom stock units aligns the director's interests with the long-term performance of Pfizer.
• The Nonfunded Deferred Compensation and Unit Award Plan is a common practice to incentivize and retain non-employee directors.

Future Outlook

The phantom stock units will be settled in cash or common stock at the director's election following retirement from the Board of Directors.

Industry Context

Reporting of beneficial ownership changes by company insiders is standard practice and required by the SEC to ensure transparency and prevent insider trading. Deferred compensation plans are common for directors.

Comparison to Industry Standards

• Deferred compensation plans for non-employee directors are a common practice among publicly traded companies, including those in the pharmaceutical industry.
• Companies like Johnson & Johnson and Merck also utilize similar compensation structures to align director interests with shareholder value.

Stakeholder Impact

• The acquisition of phantom stock units by a director can positively influence shareholder confidence by aligning director interests with the company's long-term success.

Key Dates